The global traumatic brain injuries (TBIs) assessment and management market was valued at USD 2.807 billion in 2022. It is estimated to reach USD 5.074 billion by 2031, growing at a CAGR of 6.8% during the forecast period (2023–2031).
Traumatic Brain Injury (TBI) assessment and management refers to the assessment and treatment of people who have experienced an injury to the brain due to a trauma or external force. TBI can occur due to various incidents such as falls, motor vehicle accidents, sports injuries, or assaults. The assessment of traumatic brain injuries typically involves a comprehensive evaluation by medical professionals, including neurologists, neurosurgeons, or rehabilitation specialists. It may include a detailed medical history, physical examination, neuroimaging scans (such as CT or MRI), and cognitive assessments to determine the severity and specific areas of brain damage.
The management of traumatic brain injuries depends on the severity and specific symptoms experienced by the individual. It often involves a multidisciplinary approach and may include several components. The first component is stabilization, which involves immediate medical interventions to ensure the person's overall stability and prevent further injury or complications. The second component is acute medical care, where individuals receive intensive care and monitoring to manage any life-threatening conditions or complications that may arise following the injury.
The global TBI assessment and management market is driven by the growing incidence of traumatic brain injuries (TBIs) resulting from increasing sports injuries and road accidents. One of the main elements causing the rise in TBIs is the growing participation in sports and recreational activities. As more people engage in physical activities, the risk of sports-related injuries, including TBIs, increases. Football, soccer, and hockey have been particularly associated with a higher likelihood of TBIs, especially concussions. This has prompted increased awareness and concern about the long-term consequences of TBIs in athletes of all ages and levels of competition.
Road accidents are another significant contributor to the increasing incidence of TBIs. The risk of accidents and subsequent head injuries has risen with the expansion of transportation infrastructure and the increase in traffic-related vehicles. Motor vehicle accidents, motorcycle crashes, and pedestrian accidents are common causes of TBIs. The impact of these accidents can result in varying degrees of brain damage and neurological impairments.
The growing incidence of TBIs due to sports injuries and road accidents has become a significant driver for the TBI assessment and management market. As the demand for effective assessment, diagnosis, and management solutions continues to rise, the market is anticipated to experience a further increase in the upcoming years. This presents opportunities for healthcare providers, technology developers, and researchers to contribute to developing and improving TBI assessment and management strategies, ultimately improving outcomes for individuals affected by TBIs.
Brain injury is a leading cause of trauma-associated disability and mortality worldwide. TBIs may damage or block blood vessels, which can cause circulation problems or bleeding in the brain. Invasive or minimally invasive surgical techniques treat blocked blood vessels in the brain. Minimally invasive techniques are preferred for removing or repairing hematomas (ruptured blood vessels) or contusions (bruised brain tissue) after brain injury.
Currently, most TBIs can be primarily handled using specific modern technologies, such as MRI or CT scanning, transcranial Doppler ultrasound, intraoperative navigation, and endoscopy, to attain the best excision effect through a minimally invasive approach to the scalp. Such specialized instrumentation makes it feasible for neurosurgeons to reach deep lesions in the brain through a pinhole-sized opening in the skull without damaging surrounding tissue. These devices are mostly used to maintain cerebral blood flow and oxygen delivery, optimize intracranial pressure, minimize cerebral edema, and provide a healthy metabolic environment.
Regulatory policies regarding medical devices vary in different countries. The level of regulatory control on a medical device is based on a risk-based approach determined by the CDRH. According to the U.S. FDA, medical devices, such as CT scans, MRIs, and ICP monitoring devices, are classified as Class II devices commonly used to assess mild or severe TBIs. Regulatory recommendations are required to promote and ensure such devices' safe and effective usage. These devices are subjected to rigorous clinical trials before Premarket Approval (PMA), which takes a minimum of 5 to 10 years. These clinical trials lead to a substantial increase in the costs for manufacturers.
In addition, manufacturers must also adhere to standard guidelines established by Medical Devices Directive (MDD) while manufacturing products. Regulatory requirements for medical devices vary around the world, which increases complexities for manufacturers while entering into a market. Such factors hinder market growth.
The economic growth in developed countries, such as the United States and Germany, presents significant growth opportunities for manufacturers in the global TBI assessment and management market. As these countries experience economic growth, there is an expansion of healthcare infrastructure, increased healthcare expenditure, and a greater focus on improving patient outcomes. This creates a favorable environment for manufacturers of TBI assessment and management devices to expand their sales and distribution networks. With an increasing emphasis on healthcare and the availability of resources, manufacturers can establish and strengthen their presence in these markets. They can collaborate with healthcare providers, hospitals, and research institutions to introduce their products and solutions for TBI assessment and management.
Expanding sales and distribution networks in these developed countries can give manufacturers access to a larger customer base and a broader market reach. This enables them to showcase their innovative technologies and establish partnerships with healthcare organizations to adopt and implement their products. Moreover, economic growth leads to higher disposable incomes and increased healthcare spending in these countries. This drives the demand for advanced medical devices and technologies, including TBI assessment and management solutions. In addition, manufacturers can capitalize on this growing demand by offering state-of-the-art products and leveraging economic prosperity to drive sales and market expansion. By expanding their sales and distribution networks in these regions, manufacturers can tap into the increasing demand for advanced medical technologies and establish themselves as key players in the market.
The global traumatic brain injuries (TBIs) assessment and management market is bifurcated into technique and end-user.
Based on technique, the global traumatic brain injuries (TBIs) assessment and management market is bifurcated into partial pressure of oxygen in brain tissue (pBrO2), intracranial pressure monitoring, and others.
The partial pressure of oxygen in brain tissue (pBrO2) segment dominates the global market and is expected to exhibit a CAGR of 7.21% over the forecast period. pBrO2 monitoring systems treat patients suffering from TBI and other cerebrovascular events such as stroke, encephalopathies, and aneurysm rupture. Shortage of brain oxygen is a major cause of death in TBI, as even small periods of hypotension and hypoxia can drastically boost mortality. Patients with severe TBI are at further risk of injury due to cerebral ischemia and hypoxia. Thus, they are advised to continue pBrO2 monitoring. It collects accurate and timely information about cerebral oxygen delivery and demand.
The brain has very limited reserves of oxygen and glucose, and it depends on a continuous and sufficient flow of blood to provide glucose and oxygen to meet its metabolic demand. However, an acute brain injury can disrupt normal oxygen delivery and increase metabolic demand. The pBrO2 monitoring systems enable continuous monitoring of the partial pressure of oxygen in brain tissue, providing an early indication of hypoxic events. As a result, this system allows timely intervention to restore oxygen delivery. For instance, the Licox Brain Tissue Oxygen Monitoring System offered by Integra NeuroSciences is used to continuously monitor pBrO2, intracranial temperature, and intracranial pressure.
Based on end-user, the global traumatic brain injuries (TBIs) assessment and management market is bifurcated into hospitals, diagnostic centers, ambulatory surgical centers, emergency clinics, and research centers.
The hospital segment owns the highest market share and is projected to exhibit a CAGR of 7.12% over the forecast period. The expansion of the hospital market growth of the hospital segment in the TBIs assessment and management market can be attributed to various factors. Firstly, TBIs are growing worldwide, primarily caused by sports injuries, road accidents, and assaults. The CDC reported that in 2014 there were millions of hospitalizations, emergency department visits, and deaths in the United States alone related to TBIs. This indicates the significant burden of TBIs and the need for effective assessment and management in a hospital setting. The rising number of TBIs translates into increased demand for hospital treatment, as hospitals have the necessary infrastructure, resources, and expertise to handle such cases.
Secondly, hospitals are at the forefront of technological advancements in the healthcare industry. The complex nature of brain examination and TBI assessment requires sophisticated and expensive equipment primarily available in hospitals. Technologically advanced devices are extensively used in hospitals to provide patients with improved treatment results with TBIs. These devices simplify treatment procedures and deliver faster and more accurate results, aiding in effective diagnosis and management. The presence of advanced equipment and professional neurologists in specialty hospitals enables comprehensive assessment and treatment of severe TBIs and other neurological disorders.
Based on region, the global traumatic brain injuries (TBIs) assessment and management market is bifurcated into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
North America is the most significant global traumatic brain injuries (TBIs) assessment and management market shareholder and is estimated to grow at a CAGR of 6.2% over the forecast period. North America's dominant position in the TBIs assessment and management devices market can be attributed to several factors. There has been an increase in TBIs in North America. This rise is primarily due to sports injuries, road accidents, and falls. The growing awareness of TBIs and their potential long-term effects has led to an increased focus on assessing and managing these injuries. This drives the demand for TBIs assessment and management devices in the region.
North America benefits from a well-established healthcare infrastructure. The region has advanced healthcare facilities, including specialized hospitals and trauma centers equipped to handle complex TBIs. The availability of state-of-the-art medical equipment and technologies in these healthcare institutions supports accurate assessment and management of TBIs. The presence of skilled healthcare professionals, including neurologists, neurosurgeons, and radiologists, further contributes to the region's effective management of TBIs.
Europe is predicted to exhibit a CAGR of 6.7% over the forecast period. Europe's position as the second-largest market for TBIs assessment and management devices is driven by several factors. Firstly, Europe has a significant incidence of TBIs, with road accidents being a major contributor. According to the Annual Accident Report 2017 by the European Road Safety Observatory, in 2015, approximately 1.4 million people were injured in road accidents in Europe. This highlights the need to effectively assess and manage TBIs in the region. The increasing incidence of TBIs and the rising awareness of their consequences drive the demand for advanced devices and technologies for assessment and management.
Secondly, Europe is known for its advanced technologies and well-established healthcare infrastructure. The region has a robust healthcare system, which includes specialized hospitals, trauma centers, and rehabilitation facilities. These institutions have state-of-the-art medical equipment and technologies, allowing for accurate diagnosis and comprehensive management of TBIs. The presence of skilled healthcare professionals, including neurologists, neurosurgeons, and radiologists, further enhances the region's capabilities in addressing TBIs.
The Asia-Pacific area offers several prospects for expansion for the TBIs assessment and management market, driven by a large target population, high unmet needs, increasing clinical trials and R&D investments, crashes on the road going up, and government initiatives. Addressing challenges related to healthcare infrastructure, skilled professionals, and reimbursement facilities will be essential for unlocking the market's full possibilities.
Latin America presents significant growth opportunities for the TBIs assessment and management market due to increasing healthcare expenditure and rising penetration of health insurance in the region. The region's healthcare expenditure is rising as a proportion of GDP, indicating a greater focus on healthcare services. Countries like Brazil, Argentina, Mexico, and Chile have shown considerable healthcare expenditure, which signifies the willingness to invest in healthcare infrastructure and services.
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends|
"Find new revenue generation opportunities"